Children's understanding of cystic fibrosis

M G Harbord1, D G Cross, F Botica

  • 1Department of Psychiatry, Adelaide Children's Hospital, South Australia.

Australian Paediatric Journal
|August 1, 1987
PubMed

Insights

Children with cystic fibrosis show developing knowledge of their illness with age. However, younger children (4-6 years) exhibit more positive attitudes toward therapy and self-management than older age groups.

Area of Science:

  • Pediatric Psychology
  • Pediatric Pulmonology

Background:

  • Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs.
  • Understanding of illness and attitudes towards therapy can impact treatment adherence and outcomes in pediatric patients.

Purpose of the Study:

  • To investigate the understanding and attitudes towards cystic fibrosis in children across different age groups.
  • To compare these perceptions with cognitive development stages.

Main Methods:

  • Interviewed 61 children (aged 4-18 years) with cystic fibrosis.
  • Compared responses across three age groups (4-6, 7-11, 12-18 years).
  • Correlated findings with Piagetian stages of cognitive development.

Main Results:

  • Knowledge of cystic fibrosis increased with age.
  • Younger children (4-6 years) reported more positive self-perceptions and therapy effects compared to older groups.
  • The 7-11 year group showed the least positive outlook on therapy benefits and CF, despite better clinical scores.

Conclusions:

  • Cognitive development influences children's understanding of cystic fibrosis.
  • Attitudes towards CF and its therapy are complex and vary significantly by age.
  • Interventions may need to be tailored to address age-specific psychological needs and perceptions in pediatric CF care.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Transcellular Transport of Solutes01:23

Transcellular Transport of Solutes

Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...